Unknown PHASE3 INTERVENTIONAL 2-arm NCT03973008

Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma

Phase III, Randomized, Open-label Study of Adjuvant Chemotherapy Combined With Chemoradiotherapy Versus Adujvant Chemotherapy After Standard D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma

Sponsor: Zhejiang Cancer Hospital

Conditions Gastric Adenocarcinoma

Interventions Adjuvant Chemoradiotherapy Adjuvant Chemotherapy

Updated 5 times since 2019 Last updated: Jun 1, 2019 Started: Mar 11, 2019 Primary completion: Feb 29, 2024 Completion: May 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Gastric Adenocarcinoma and is currently ongoing. Zhejiang Cancer Hospital leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Jul 2025 — Present [monthly]

Unknown PHASE3

Status: Recruiting → Unknown
Sep 2024 — Jul 2025 [monthly]

Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE3
Jan 2021 — Jul 2024 [monthly]

Recruiting PHASE3
Jul 2019 — Jan 2021 [monthly]

Recruiting PHASE3

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zhejiang Cancer Hospital

Data source: Zhejiang Cancer Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China